文献速递血液透析通路慢性静脉疾病

系统综述:动静脉内瘘结扎对肾移植受者高输出量心力衰竭的影响

A Systematic Review Exploring the Impact of Arteriovenous Fistula Ligature on High-Output Heart Failure in Renal Transplant Recipients.
PubMed 文献 · Ann Vasc Surg · 2023-12-19

本系统综述遵循PRISMA 2020指南,检索多个数据库,纳入16项研究共18,735例受试者,评估肾移植受者结扎有功能的动静脉内瘘对高输出量心力衰竭的影响。结果显示结扎后左心室质量、左心室质量指数、左心室舒张末期内径、心输出量、速度指数及体循环血管阻力指数均显著降低,结论认为结扎后可预期高输出量心力衰竭的临床体征和症状完全缓解。

要点

  • 肾移植受者结扎动静脉内瘘后左心室质量及心输出量等指标显著降低。
  • 结扎动静脉内瘘后可预期高输出量心力衰竭的临床体征和症状完全缓解。
  • 临床医生应始终警惕无症状肾移植受者出现心血管失代偿的体征和症状。

核心结论

  • 肾移植受者结扎动静脉内瘘后可预期高输出量心力衰竭的临床体征和症状完全缓解。
  • 临床医生应始终警惕无症状肾移植受者出现心血管失代偿的体征和症状。

研究设计与样本

  • 本系统综述采用PRISMA 2020指南,检索PubMed、Scopus、PubMed Central、Science Direct和Medline数据库,纳入过去十年发表、涉及人类、仅限英文、包含男女性别及年龄大于19岁成人人群的研究。
  • 最终纳入16项研究共18,735例受试者,包括6项队列研究、4项病例报告、2项随机对照试验、2项叙述性综述、1项Meta分析和1项病例系列。

主要发现

  • 电子检索共获得1,461篇文章,经资格标准筛选后纳入16项研究共18,735例受试者。
  • 在报告性别的12项研究中,男性10,949例,女性6,416例。
  • 结扎动静脉内瘘后,左心室质量、左心室质量指数、左心室舒张末期内径、心输出量、速度指数及体循环血管阻力指数均显著降低。
  • 叙述性综述的偏倚风险低,1项随机对照试验存在一些总体担忧,纳入的Meta分析偏倚风险为中等,6项队列研究中4项质量良好,所有病例报告和病例系列质量良好。

临床怎么用

  • 作者认为,肾移植受者结扎动静脉内瘘后可预期高输出量心力衰竭的临床体征和症状完全缓解。
  • 作者认为,临床医生应始终警惕无症状肾移植受者出现心血管失代偿的体征和症状。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cardiovascular disease is the most common cause of death in renal transplant recipients (RTrs). High-output heart failure (HoHF) is a classic problem of RTrs with patent arteriovenous fistulae (AVF). Central to the entire discipline of transplant nephrology is the ligation of AVF in RTrs, with a patent AVF presenting with signs and symptoms of HoHF. AVF ligation has long been a topic of great interest in this population. To date, little attention has been paid to the effects of arteriovenous graft ligation on HoHF. This study systematically reviews the data for AVF ligation, aiming to provide its impact on HoHF in RTrs. METHODS: The present study adopts the Preferred Reporting Items for Systematic Reviews and Meta-analysis 2020 guidelines. Published studies were identified using a search strategy in PubMed, Scopus, PubMed Central, Science Direct, and Medline. The primary inclusion criterion for this review was RTrs with a patent AVF who exhibited clinical or imaging findings of HoHF. Articles dating back to the last decade that involved the human species were included in our review, and the search was restricted to the English language. Studies involving both male and female genders and those describing the adult population (aged > 19 years) were also a part of our inclusion criteria. RESULTS: After applying eligibility criteria, our electronic search yielded 1,461 articles. A total of 16 studies that involved 18,735 subjects were included in our review, which comprised 6 cohort studies, 4 case reports, 2 randomized control trials, 2 narrative reviews, 1 meta-analysis, and 1 case series. While the risk of bias of the narrative reviews was low, 1 of the randomized control trials had some overall concerns. The meta-analysis included in our review had moderate risk of bias, while 4 of the 6 cohort studies were of good quality. All of the case reports and series included in our review were of good quality. Of the 12 studies that reported genders, 10,949 were male and 6,416 were female. There was a notable reduction in left ventricular mass, left ventricular mass index, left ventricular end diastolic dimension, cardiac output, velocity index, and systemic vascular resistance index upon AVF ligation. CONCLUSIONS: A complete resolution of the clinical signs and symptoms of HoHF can be anticipated after AVF ligation in RTrs. Clinicians should always be on the lookout for signs and symptoms of cardiovascular decompensation in asymptomatic RTrs.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Yasir MB, Man RK, Gogikar A, et al. A Systematic Review Exploring the Impact of Arteriovenous Fistula Ligature on High-Output Heart Failure in Renal Transplant Recipients. Ann Vasc Surg. 2023. PMID: 38122973. doi:10.1016/j.avsg.2023.10.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。